Beranda › Leukemia-Limfoma Limfoblastik Sel T Prekursor › Texas › Houston
Uji klinis Leukemia-Limfoma Limfoblastik Sel T Prekursor di Houston, TX
8 studi untuk Leukemia-Limfoma Limfoblastik Sel T Prekursor mencari peserta di lokasi sekitar Houston (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
Menerima pesertaFase 2
- MD Anderson Cancer Center, Houston
A Phase 2 Study to Evaluate Efficacy of Calaspargase Pegol-mknl and Decitabine Combined With Venetoclax in Pediatric, Adolescent, and Young Adult Patients With Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia (T-ALL) and T- Cell Lymphoblastic Lymphoma (T-LLy)
Menerima pesertaFase 2
- MD Anderson Cancer Center, Houston
Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With High Risk T-Cell ALL & Lymphoma
Menerima pesertaFase 1
- MD Anderson Cancer Center, Houston
Venetoclax, Dexamethasone, Bortezomib, and Daratumumab For The Treatment Of Adolescent And Young Adults With Relapsed Or Refractory T-Cell Acute Lymphoblastic Leukemia And T-cell Acute Lymphoblastic Lymphoma
Menerima pesertaFase 1
- UT MD Anderson, Houston
Autologous T-Cells Expressing a Second Generation CAR for Treatment of T-Cell Malignancies Expressing CD5 Antigen
Menerima pesertaFase 1
- Houston Methodist Hospital, Houston
- Texas Children's Hospital, Houston
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Menerima pesertaFase 2
- M D Anderson Cancer Center, Houston
A Registry for People With T-cell Lymphoma
Menerima pesertaStudi observasional
- MD Anderson Cancer Center (Data Collection Only), Houston
Novel Unedited Allo Cell Therapy For High Risk T-Cell Malignancies Using CD7-Specific Car T Cells
Menerima pesertaFase 1
- Houston Methodist Hospital, Houston
- Texas Children's Hospital, Houston
Uji klinis Leukemia-Limfoma Limfoblastik Sel T Prekursor di kota lain
- New York City, NY6 studi
- Columbus, OH5 studi
- Washington, DC4 studi
- Philadelphia, PA4 studi
- Baldwin Park, CA3 studi
- St. Louis, MO3 studi
- Boston, MA3 studi
- Edison, NJ3 studi
- Queens, NY3 studi
- New Rochelle, NY3 studi
- Staten Island, NY3 studi
- East Norwalk, CT3 studi
Studi lain di Houston
- Kanker Paru Non-Sel Kecil145 studi
- Kanker Payudara126 studi
- Kanker (semua jenis)121 studi
- Kanker Metastatik104 studi
- Kanker Kolorektal102 studi
- Kanker Ovarium89 studi
- Leukemia Mieloid Akut85 studi
- Kanker Paru78 studi
- Kanker Prostat76 studi
- Kanker Endometrium68 studi
- Kanker Pankreas61 studi
- Melanoma59 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.